Headline
The latest stories from AHA Today.
The House Energy and Commerce Subcommittee on Health voted to advance to the full committee a number of AHA-supported bills focused on maternal health and social determinants of health.
The House Appropriations Committee voted 33-25 to approve legislation that would provide $253.8 billion in funding for the departments of Labor, Health and Human Services, and Education in fiscal year 2022, a 28% increase over the prior fiscal year.
In a letter sent to the Centers for Medicare & Medicaid Services, AHA expressed its continued concerns about audit determinations denying hospitals a “mid-build exception” to the site-neutral payment policy and urged the agency to extend by at least 180 days the July 18 and Sept. 16 deadlines…
Congress should not extend Medicare sequestration to help pay for the bipartisan infrastructure framework because health care providers cannot sustain additional Medicare cuts and Medicare funds should not be used to pay for non-health care programs, the AHA, American Medical Association, American…
Alison Brisson, a member of AHA’s American Society for Health Care Engineering affiliate and director of facilities at Concord Hospital in New Hampshire, shares her reasons for getting the COVID-19 vaccine as part of AHA’s ongoing #MyWhy social media campaign to encourage vaccine confidence among…
Over 1.5 million people selected a 2021 health plan through the federally facilitated marketplace between Feb. 15 and June 30 during the special enrollment period created in response to the COVID-19 emergency, with an additional 600,000 enrolling through the 15 state-based marketplaces, the…
The Centers for Medicare & Medicaid Services is accepting comments through Aug. 11 on whether to establish a national Medicare coverage policy for monoclonal antibodies to treat Alzheimer’s disease.
Drug overdose deaths in the United States rose 29.4% in 2020 to an estimated 93,331, including 69,710 involving opioids, according to preliminary data released by the Centers for Disease Control and Prevention
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will convene July 22 to discuss a pair of recent issues related to COVID-19 vaccines.
The Senate Judiciary Committee Subcommittee on Competition Policy, Antitrust, and Consumer Rights held a hearing on surging drug prices and anticompetitive conduct in the pharmaceutical industry.